Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

BP's greatest friend in a BO is Iljin

By keeping the price depressed, the BO premium is kept artificially low.

I'm thinking a horde of discouraged retail holders might already have (or will soon) given up on holding this.

I think Jess called for something like $20-25 after FDA approval with the 2037 label, and I thought he had it exactly right.

But here we are at a pathetic $16-17

I can't see what changes here until Lupkynis racks up some impressive sales numbers.

Hopefully, they are on the way.

cheers